Tilray | TRLY - Receita De Vendas

Preço das Ações
9.47
Mudança Diária
-0.08 -0.84%
Mensal
-9.03%
Anual
886.46%
Q1 Previsão
9.24




Vendas Alterar Data
Acasti Pharma USD -4.76M 4.76M 2024-12
Akebia Therapeutics USD 57.34M 10.84M 2025-03
Alaunos Therapeutics USD 2K 2K 2025-03
Aurora Cannabis CAD 90.37M 7.65M 2025-09
Avita Medical AUD 17.61M 805K 2025-12
Canopy Growth CAD 66.68M 5.45M 2025-09
Cronos Group USD 58.39M 22.05M 2025-12
Dianthus Therapeutics USD 396K 203K 2025-09
Divis Laboratories Ltd INR 26.04B 1.11B 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Knight Therapeutics CAD 121.55M 14.19M 2025-09
Moderna USD 678M 342M 2025-12
Organigram Holdings CAD 80.06M 9.27M 2025-09
Organon & Co USD 1.51B 90M 2025-12
Revvity USD 772.06M 73.06M 2025-12
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Viatris USD 3.7B 60M 2025-12
Xeris Pharmaceuticals USD 74.38M 2.84M 2025-09